Literature DB >> 20491447

Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis.

Hongcheng Liu1, Chris Chumsae, Georgeen Gaza-Bulseco, Karen Hurkmans, Czeslaw H Radziejewski.   

Abstract

One of the basic structural features of human IgG1 is the arrangement of the disulfide bond structure, 4 inter chain disulfide bonds in the hinge region and 12 intra chain disulfide bonds associated with twelve individual domains. Disulfide bond structure is critical for the structure, stability, and biological functions of IgG molecules. It has been known that inter chain disulfide bonds are more susceptible to reduction than intra chain disulfide bonds. However, a complete ranking of the susceptibility of disulfide bonds in IgG1 molecules is lacking. A method including reduction, differential alkylation, and liquid chromatography-mass spectrometry (LC-MS) analysis was developed and employed to investigate the complete ranking order of the susceptibility of disulfide bonds in two recombinant monoclonal antibodies. The results confirmed that inter chain disulfide bonds were more susceptible than intra chain disulfide bonds. In addition, it was observed that the disulfide bonds between the light chain and heavy chain were more susceptible than disulfide bonds between the two heavy chains. The upper disulfide bond of the two inter heavy chain disulfide bonds was more susceptible than the lower one. Furthermore, disulfide bonds in the CH2 domain were the most susceptible to reduction. Disulfide bonds in VL, CL, VH, and CH1 domains had similar and moderate susceptibility, while disulfide bonds in the CH3 domain were the least susceptible to reduction. Interestingly, a difference between IgG1kappa and IgG1lambda was also observed. The difference in the susceptibility of inter light heavy chain disulfide bonds and inter heavy chain disulfide bonds was smaller in IgG1kappa than in IgG1lambda. The intra chain disulfide bonds in the Fab region of IgG1kappa were also less susceptible than disulfide bonds in the Fab region of IgG1lambda.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20491447     DOI: 10.1021/ac100575n

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  37 in total

1.  Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates.

Authors:  Mauro Acchione; Hyewon Kwon; Claudia M Jochheim; William M Atkins
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

2.  Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.

Authors:  Katariina M Hutterer; Robert W Hong; Jonathon Lull; Xiaoyang Zhao; Tian Wang; Rex Pei; M Eleanor Le; Oleg Borisov; Rob Piper; Yaoqing Diana Liu; Krista Petty; Izydor Apostol; Gregory C Flynn
Journal:  MAbs       Date:  2013-04-18       Impact factor: 5.857

Review 3.  Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.

Authors:  Satish K Singh; Donna L Luisi; Roger H Pak
Journal:  Pharm Res       Date:  2015-05-19       Impact factor: 4.200

4.  Expression vector-derived heterogeneity in a therapeutic IgG4 monoclonal antibody.

Authors:  Douglas S Rehder; Chris J Wisniewski; Denfeng Liu; Diya Ren; Dell Farnan; Matthew R Schenauer
Journal:  MAbs       Date:  2018-11-07       Impact factor: 5.857

5.  Asymmetric peptide dendrimers are effective linkers for antibody-mediated delivery of diverse payloads to b cells in vitro and in vivo.

Authors:  Neha D Shah; Harendra S Parekh; Raymond J Steptoe
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

6.  A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization.

Authors:  Yan An; Ying Zhang; Hans-Martin Mueller; Mohammed Shameem; Xiaoyu Chen
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

7.  Simplified identification of disulfide, trisulfide, and thioether pairs with 213 nm UVPD.

Authors:  James Bonner; Lance E Talbert; Nicholas Akkawi; Ryan R Julian
Journal:  Analyst       Date:  2018-10-22       Impact factor: 4.616

8.  Characterization of monoclonal antibody size variants containing extra light chains.

Authors:  Connie Lu; Dandan Liu; Hongbin Liu; Paul Motchnik
Journal:  MAbs       Date:  2012-12-19       Impact factor: 5.857

9.  Effect of trastuzumab interchain disulfide bond cleavage on Fcγ receptor binding and antibody-dependent tumour cell phagocytosis.

Authors:  Mami Suzuki; Ayaka Yamanoi; Yusuke Machino; Michiko Ootsubo; Ken-ichi Izawa; Junya Kohroki; Yasuhiko Masuho
Journal:  J Biochem       Date:  2015-08-08       Impact factor: 3.387

10.  Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring.

Authors:  Dan Li; Shuanglong Liu; Ren Liu; Ryan Park; Lindsey Hughes; Valery Krasnoperov; Parkash S Gill; Zibo Li; Hong Shan; Peter S Conti
Journal:  Mol Pharm       Date:  2012-12-18       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.